SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense investor scrutiny as a significant rise in AI infrastructure spending and substantial legal costs triggered an earnings miss and lukewarm future guidance. The community is sharply divided, with some investors panic-selling over margin compression and heavy capital expenditure, while others characterize the dip as a long-term buying opportunity in a dominant digital advertising company.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors react to a strong earnings report and cloud growth that eased concerns about high capital expenditure on AI. The community is actively discussing the stock's role as a potential safe haven in a volatile market, with many pointing to Azure's resilience and management's focus on long-term capital efficiency.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad regulatory approval of Anktiva for bladder and lung cancer, sparking significant community excitement over its growing international footprint and potential to bypass domestic regulatory hurdles. Investors and the community are actively debating the stock's future, balancing optimism for upcoming quarterly earnings and potential global partnerships against frustration with ongoing price volatility and short-selling pressure.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF is trending as rising geopolitical tensions in the Middle East drive oil prices higher and fuel investor fears of persistent inflation. Community sentiment is currently split, with many traders analyzing the inverse relationship between surging yields and equity market stability while discussing whether this environment signals an impending recession or a long-term bottom for bonds.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny as investors weigh the stock's recent price stagnation against the heavy capital expenditure requirements for AI infrastructure and data center expansion. The community remains divided, with many traders closely monitoring AWS performance and management's guidance on long-term AI profitability ahead of upcoming earnings.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are under significant pressure as investors rotate out of growth names amid broader market volatility and uncertainty heading into the upcoming earnings report. The community remains deeply divided, with some highlighting strong fundamental growth and new business lines as a reason to buy the dip, while others express frustration over recent price declines and concerns about market manipulation.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is seeing significant volatility as investors weigh the potential for a third FDA resubmission against lingering skepticism regarding trial design and clinical data quality. Community sentiment remains polarized, with many traders speculating on a regulatory lifeline or potential short-squeeze, while others cite recurring concerns over trial design and the company's long-term capital requirements.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing extreme volatility and heavy selling pressure as traders grapple with geopolitical tensions in Iran, rising 30-year bond yields, and conflicting reactions to the recent FOMC decision. The community is sharply divided between those bracing for a deeper market correction driven by sector rotation and those hunting for tactical bounces fueled by mega-cap tech earnings.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 ETF is facing significant volatility as investors weigh the impact of rising global bond yields, energy price shocks, and geopolitical instability against broader rotation themes. Community discussion is heavily focused on the disconnect between the index's resilience in the face of macro headwinds and the underlying pressure on small-cap liquidity, with many traders actively debating whether the current price action signals a healthy rotation or the precursor to a deeper market correction.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is experiencing heightened volatility and trader attention as the community weighs conflicting catalysts, including anticipation for the Clarity Act's legislative progress and looming Q2 earnings. Investors are actively debating whether the stock represents a deep-value buying opportunity or a short-squeeze candidate, with sentiment sharply divided over the impact of potential regulatory clarity on the company's long-term growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress  

Equity

Viking has no approved drug products, and in the pre-revenue phase, investor attention centers almost entirely on clinical progress.

Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update PR Newswire SAN DIEGO, July 29, 2026 Conference call scheduled for 4:30 p.m. ET today-- Phase 3 VANQUISH 1...

How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q2 Results?

Novo Nordisk's Q2 results are set to spotlight Ozempic and Wegovy sales as oral launches and label expansions drive growth amid mounting competitive pressure.

Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?

Biotech earnings take center stage as Viking, Biogen, Bristol Myers, Regeneron and AbbVie prepare to report Q2 2026 results.

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

LLY's Retatrutide Nears 2027 Filing With Two More Phase III Wins

Eli Lilly's retatrutide meets the primary endpoint in the phase III TRIUMPH-2 & TRIUMPH-3 studies, supporting planned regulatory submissions for obesity in 2027.

Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market

Viking Therapeutics, Inc. (VKTX) reached $35.39 at the closing of the latest trading day, reflecting a -5.15% change compared to its last close.

How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q2 Results?

LLY's blockbuster GLP-1 portfolio takes center stage as investors watch Mounjaro, Zepbound and Foundayo for clues to Q2 growth and outlook.

Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors

Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors PR Newswire SAN DIEGO,, July 23, 2026 Experienced Executive Brings Over Two Decades of Leadership Across Healthcare, Digital Health and CommercializationSAN DIEGO...

Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower 

Drugmakers have announced 37 biotech acquisitions worth at least $1 billion this year, topping the previous annual record.

$VKTX Q2 &#39;26 Earnings Results &amp; Recap

Reported GAAP EPS of -$1.10 down -89.66% YoY

Stocktwits

Viking Therapeutics Inc

 Q2 '26 Earnings Results & Recap

Reported GAAP EPS of -$1.10 down -89.66% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$VKTX Q2 '26 Earnings Results & Recap

Reported GAAP EPS of -$1.10 down -89.66% YoY

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits Polls

Investors are eagerly anticipating the Q3 maintenance dosing data as a potential clinical validator for their obesity pipeline.

The stock remains a hotbed for M&A rumors, with persistent speculation that pharma giants are circling the high-value asset.

Tensions are running high as bulls challenge the massive short interest and accuse traders of manipulating price action via volume games.

Frustration is mounting among some shareholders regarding executive communication styles and persistent insider selling.

Current Price	$33.43
Prev Close	$33.86
Open	$33.86
Dividend Yield	0.00%
50-Day Moving Average	$33.86
Beta	1.63
Avg. Volume	2.77M
PE Ratio	-8.06

52-Week High	$43.15
52-Week Low	$22.96
Market Capitalization	$3.93B
EPS (Annual)	-$3.19
Price to Book	7.72
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

VKTXViking Therapeutics Inc

Latest VKTX News